World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics
By S. Shrivastava, P. Shrivastava, J. Ramasamy. 2018
2,254 citations recorded by the source corpus.
Subfields: Applied Microbiology and Biotechnology, Economics and Econometrics
View Paper: https://www.semanticscholar.org/paper/0bb458dcea950469dfca57dea37cdc7afd1bc5ff
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
Citations in the corpus
- Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis (2022, methodology): “34 WHO has explained that the absence of MDR tuberculosis from its priority list is because it has already been established globally as a top priority for innovative treatments, but this exclusion remains a source of considerable debate.”
- Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 (2024, positive): “33 To calculate attributable years lived with disability (YLDs), we took the product of the infectious syndrome incidence (appendix 1 pp 27–32), the fraction of infectious syndrome incident cases attributable to each pathogen, YLDs per incident case, and the non-fatal PAF.”
- CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database (2022, background): “the World Health Organization’s (WHO) priority list of antibiotic resistant bacteria (2,25).”
- Structural insights into the mycobacteria transcription initiation complex from analysis of X-ray crystal structures (2017, background): “Continued emergence of multi-antibiotic resistant bacteria present the sobering reality that the clinical anti-bacterial arsenal is becoming increasingly depleted 56 .”
- Identification of antimicrobial peptides from the human gut microbiome using deep learning (2022, methodology): “We set three experimental groups to test c_AMP antibacterial activity: (1) blank control group, 200 μl of LB solution; (2) bacterial control group, 100 μl of LB solution and 100 μl of bacterial solution; and (3) low-c_AMPs group (60 μmol L−1), 100 μl of LB solution, 95 μl of bacterial solution and 5”